Three doses of HPV vaccine still recommended, for nowBMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f2797 (Published 01 May 2013) Cite this as: BMJ 2013;346:f2797
Vaccines against human papilloma viruses (HPV) are immunogenic in young girls and we know they prevent clinical disease in young women. So trials testing different dose schedules in young girls aim for immune responses as good as the effective immune responses achieved in …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial